SC
IONS icon

Slow Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Slow Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40
Closed -$2K – 224
2020
Q3 		$2K Buy
+40
New +$2.22K ﹤0.01% 285
2018
Q1 		– Sell
-15,669
Closed -$788K – 208
2017
Q4 		$788K Buy
+15,669
New +$859K 0.41% 84

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Slow Capital's IONS Position: Q4 2020 in Review

Slow Capital sold out of Ionis Pharmaceuticals (IONS) in Q4 2020, closing a stake of 40 shares — an estimated $2K sold.

Slow Capital first reported a position in IONS in Q4 2017 and held it in 2 quarters. The position peaked at $788K in Q4 2017. 382 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

  • Slow Capital reported no remaining Ionis Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Slow Capital sold 40 Ionis Pharmaceuticals shares in Q4 2020, an estimated $2K.
  • Slow Capital first reported a position in Ionis Pharmaceuticals in Q4 2017 and held it in 2 quarters.
  • Slow Capital's Ionis Pharmaceuticals position peaked at $788K in Q4 2017.
  • 382 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on Slow Capital's 13F filing for Q4 2020, filed 11 Feb 2021.